发明名称 |
Low Affinity FCGR Deficient Mice |
摘要 |
Genetically modified non-human animals and methods and compositions for making and using them are provided, wherein the genetic modification comprises a deletion of the endogenous low affinity FcγR locus, and wherein the mouse is capable of expressing a functional FcRγ-chain. Genetically modified mice are described, including mice that express low affinity human FcγR genes from the endogenous FcγR locus, and wherein the mice comprise a functional FcRγ-chain. Genetically modified mice that express up to five low affinity human FcγR genes on accessory cells of the host immune system are provided. |
申请公布号 |
US2015313195(A1) |
申请公布日期 |
2015.11.05 |
申请号 |
US201514800253 |
申请日期 |
2015.07.15 |
申请人 |
Regeneron Pharmaceuticals, Inc. |
发明人 |
Macdonald Lynn;Tu Naxin;Gurer Cagan;Stevens Sean;Murphy Andrew J. |
分类号 |
A01K67/027 |
主分类号 |
A01K67/027 |
代理机构 |
|
代理人 |
|
主权项 |
1. A transgenic mouse whose genome comprises a contiguous human nucleotide sequence that encodes at least two α-chains of a human FcγR α-chain gene selected from FcγRIIA, FcγRIIB, FcγRIIC, FcγRIIIA, FcγRIIIB, and a combination thereof, wherein the contiguous human nucleotide sequence replaces mouse FcγR sequences in a mouse FcγR locus, and wherein the mouse comprises a functional FcR γ-chain gene. |
地址 |
Tarrytown NY US |